241 related articles for article (PubMed ID: 31173173)
1. Hydroxysafflor Yellow A mitigated myocardial ischemia/reperfusion injury by inhibiting the activation of the JAK2/STAT1 pathway.
Zhou D; Ding T; Ni B; Jing Y; Liu S
Int J Mol Med; 2019 Aug; 44(2):405-416. PubMed ID: 31173173
[TBL] [Abstract][Full Text] [Related]
2. Synergistic cardioprotective effects of Danshensu and hydroxysafflor yellow A against myocardial ischemia-reperfusion injury are mediated through the Akt/Nrf2/HO-1 pathway.
Hu T; Wei G; Xi M; Yan J; Wu X; Wang Y; Zhu Y; Wang C; Wen A
Int J Mol Med; 2016 Jul; 38(1):83-94. PubMed ID: 27176815
[TBL] [Abstract][Full Text] [Related]
3. Protective effects of N(2)‑L‑alanyl‑L‑glutamine mediated by the JAK2/STAT3 signaling pathway on myocardial ischemia reperfusion.
Liu S; Yang Y; Song YQ; Geng J; Chen QL
Mol Med Rep; 2018 Apr; 17(4):5102-5108. PubMed ID: 29393473
[TBL] [Abstract][Full Text] [Related]
4. Hydroxysafflor yellow A protects against angiotensin II‑induced hypertrophy.
Ni B; Zhou D; Jing Y; Liu S
Mol Med Rep; 2018 Oct; 18(4):3649-3656. PubMed ID: 30132539
[TBL] [Abstract][Full Text] [Related]
5. Hydroxysafflor yellow A cardioprotection in ischemia-reperfusion (I/R) injury mainly via Akt/hexokinase II independent of ERK/GSK-3β pathway.
Min J; Wei C
Biomed Pharmacother; 2017 Mar; 87():419-426. PubMed ID: 28068632
[TBL] [Abstract][Full Text] [Related]
6. Evidence that hydroxysafflor yellow A protects the heart against ischaemia-reperfusion injury by inhibiting mitochondrial permeability transition pore opening.
Liu YN; Zhou ZM; Chen P
Clin Exp Pharmacol Physiol; 2008 Feb; 35(2):211-6. PubMed ID: 17941891
[TBL] [Abstract][Full Text] [Related]
7. Hydroxysafflor Yellow A Ameliorates Myocardial Ischemia/Reperfusion Injury by Suppressing Calcium Overload and Apoptosis.
Ye J; Wang R; Wang M; Fu J; Zhang Q; Sun G; Sun X
Oxid Med Cell Longev; 2021; 2021():6643615. PubMed ID: 34093960
[TBL] [Abstract][Full Text] [Related]
8. JLX001 improves myocardial ischemia-reperfusion injury by activating Jak2-Stat3 pathway.
Yin Q; Zhao B; Zhu J; Fei Y; Shen W; Liang B; Zhu X; Li Y
Life Sci; 2020 Sep; 257():118083. PubMed ID: 32673665
[TBL] [Abstract][Full Text] [Related]
9. Exercise-induced peptide EIP-22 protect myocardial from ischaemia/reperfusion injury via activating JAK2/STAT3 signalling pathway.
Zhang L; Wang X; Zhang H; Feng M; Ding J; Zhang B; Cheng Z; Qian L
J Cell Mol Med; 2021 Apr; 25(7):3560-3572. PubMed ID: 33710777
[TBL] [Abstract][Full Text] [Related]
10. Antioxidant effects of hydroxysafflor yellow A and acetyl-11-keto-β-boswellic acid in combination on isoproterenol-induced myocardial injury in rats.
Chen M; Wang M; Yang Q; Wang M; Wang Z; Zhu Y; Zhang Y; Wang C; Jia Y; Li Y; Wen A
Int J Mol Med; 2016 Jun; 37(6):1501-10. PubMed ID: 27121241
[TBL] [Abstract][Full Text] [Related]
11. Hydroxysafflor yellow A alleviates myocardial ischemia/reperfusion in hyperlipidemic animals through the suppression of TLR4 signaling.
Han D; Wei J; Zhang R; Ma W; Shen C; Feng Y; Xia N; Xu D; Cai D; Li Y; Fang W
Sci Rep; 2016 Oct; 6():35319. PubMed ID: 27731393
[TBL] [Abstract][Full Text] [Related]
12. JAK2/STAT3 activation by melatonin attenuates the mitochondrial oxidative damage induced by myocardial ischemia/reperfusion injury.
Yang Y; Duan W; Jin Z; Yi W; Yan J; Zhang S; Wang N; Liang Z; Li Y; Chen W; Yi D; Yu S
J Pineal Res; 2013 Oct; 55(3):275-86. PubMed ID: 23796350
[TBL] [Abstract][Full Text] [Related]
13. [Activation of JAK2/STAT3 pathway by CPU0213 alleviates myocardial ischemia-reperfusion and oxidative stress injury in rats].
Liu Y; Li Y; Li C; Wang J; Xu X; Li X
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2020 Nov; 36(11):1009-1015. PubMed ID: 33210595
[TBL] [Abstract][Full Text] [Related]
14. Protective effects of scoparone against ischemia‑reperfusion‑induced myocardial injury.
Wan C; Wei Y; Ma J; Geng X
Mol Med Rep; 2018 Aug; 18(2):1752-1760. PubMed ID: 29901189
[TBL] [Abstract][Full Text] [Related]
15. Promoting effects of IL‑23 on myocardial ischemia and reperfusion are associated with increased expression of IL‑17A and upregulation of the JAK2‑STAT3 signaling pathway.
Liao Y; Hu X; Guo X; Zhang B; Xu W; Jiang H
Mol Med Rep; 2017 Dec; 16(6):9309-9316. PubMed ID: 29039526
[TBL] [Abstract][Full Text] [Related]
16. Luteolin inhibits ROS-activated MAPK pathway in myocardial ischemia/reperfusion injury.
Yu D; Li M; Tian Y; Liu J; Shang J
Life Sci; 2015 Feb; 122():15-25. PubMed ID: 25476833
[TBL] [Abstract][Full Text] [Related]
17. Astragaloside IV Alleviates Cerebral Ischemia-Reperfusion Injury by Activating the Janus Kinase 2 and Signal Transducer and Activator of Transcription 3 Signaling Pathway.
Xu Z; Liu W; Huang H
Pharmacology; 2020; 105(3-4):181-189. PubMed ID: 31825924
[TBL] [Abstract][Full Text] [Related]
18. Matrine Protects Cardiomyocytes From Ischemia/Reperfusion Injury by Regulating HSP70 Expression Via Activation of the JAK2/STAT3 Pathway.
Guo S; Gao C; Xiao W; Zhang J; Qu Y; Li J; Ye F
Shock; 2018 Dec; 50(6):664-670. PubMed ID: 29394239
[TBL] [Abstract][Full Text] [Related]
19. Effects of dexmedetomidine postconditioning on myocardial ischemia and the role of the PI3K/Akt-dependent signaling pathway in reperfusion injury.
Cheng XY; Gu XY; Gao Q; Zong QF; Li XH; Zhang Y
Mol Med Rep; 2016 Jul; 14(1):797-803. PubMed ID: 27221008
[TBL] [Abstract][Full Text] [Related]
20. Protective effect of remifentanil on myocardial ischemia-reperfusion injury through Fas apoptosis signaling pathway.
Qu ZJ; Qu ZJ; Zhou HB; Xu CS; Zhang DZ; Wang G
Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5980-5986. PubMed ID: 31298349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
